Exon Concatenation to Increase the Efficiency of Mutation Screening by DGGE by X. Agirre, M. Garcí-Delgado, M.J. Calasanz, M.J. Larráyoz, F.J. Novo, J.L. Vizmanos

Get full text

P624: CHROMOTHRIPSIS IN PATIENTS WITH CLL AND COMPLEX KARYOTYPE: PATTERNS OF ABERRATIONS AND PROGNOSTIC VALUE by S. Ramos-Campoy, A. Puiggros, J. Kamaso, S. Beà, S. Bougeon, M. J. Larráyoz, D. Costa, H. Parker, G. M. Rigolin, M. L. Blanco, R. Collado, I. Ancín, R. Salgado, M. Moro, T. Baumann, E. Gimeno, C. Moreno, M. J. Calasanz, A. Cuneo, J. C. Strefford, F. Nguyen-Khac, D. Oscier, C. Haferlach, J. Schoumans, B. Espinet

Get full text

The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression by A. Medina-Herrera, I. Vazquez, I. Cuenca, J. M. Rosa-Rosa, B. Ariceta, C. Jimenez, M. Fernandez-Mercado, M. J. Larrayoz, N. C. Gutierrez, M. Fernandez-Guijarro, V. Gonzalez-Calle, P. Rodriguez-Otero, A. Oriol, L. Rosiñol, A. Alegre, F. Escalante, J. De La Rubia, A. I. Teruel, F. De Arriba, M. T. Hernandez, J. Lopez-Jimenez, E. M. Ocio, N. Puig, B. Paiva, J. J. Lahuerta, J. Bladé, J. F. San Miguel, M. V. Mateos, J. Martinez-Lopez, M. J. Calasanz, R. Garcia-Sanz, GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group

Get full text